The 20 Best Small Cell Lung Cancer (SCLC) Doctors Near Me in Ypsilanti, MI

Dr. Kalemkerian completed his medical education and training at Northwestern University and Johns Hopkins Oncology Center. From 1993-1999, he was a physician-scientist at Wayne State University/Karmanos Cancer Institute in Detroit. Since 1999, he has been on faculty in the Division of Hematology/Oncology at the University of Michigan, where he currently serves as the Associate Division Chief for Faculty Development and Education and the Associate Director of the Hem/Onc Fellowship Program. In addition to his work at UM, Dr. Kalemkerian has served on and led numerous grant review sections, editorial boards, and committees of national and international professional societies. He is a former chair of the NCCN Small Cell Lung Cancer Guideline Panel and the ASCO Scientific Program Committee’s Metastatic NSCLC and Professional Development and Education Tracks. Dr. Kalemkerian’s clinical interest is the care of people with lung cancer, thymic tumors, and mesothelioma, and his academic research interest is clinical and translational trials for thoracic cancers. His honors include the receipt of the American Society of Clinical Oncology’s (ASCO) Excellence in Teaching Award, the University of Michigan Outstanding Clinician Award, and Fellow of ASCO recognition. He has given over 230 invited lectures, authored more than 200 research articles, reviews, commentaries and book chapters, and edited two books on lung cancer. Dr. Kalemkerian is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma. Dr. Kalemkerian is board certified in Internal Medicine and Medical Oncology.

Thomas Regenbogen is a Hematologist practicing medicine in Ypsilanti, Michigan. Dr. Regenbogen is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Anal Cancer, and Pleuropulmonary Blastoma.

Tareq Baghdadi is a Hematologist practicing medicine in Ypsilanti, Michigan. Dr. Baghdadi is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Colorectal Cancer, Pleuropulmonary Blastoma, Tissue Biopsy, and Bone Marrow Aspiration.

Christopher Reynolds is a Hematologist practicing medicine in Ypsilanti, Michigan. Dr. Reynolds is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), Neuroendocrine Tumor, and Bone Marrow Aspiration.

Kevin Hannawa is an Interventional Radiologist practicing medicine in Ypsilanti, Michigan. He has been practicing medicine for over 18 years. Dr. Hannawa is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Smoldering Multiple Myeloma, Bone Marrow Aspiration, and Gastrostomy.

Paul Arpasi is an Interventional Radiologist practicing medicine in Ypsilanti, Michigan. Dr. Arpasi is rated as an Advanced provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Familial Prostate Cancer, Bone Marrow Aspiration, and Bone Graft.

Michael Kasotakis is a Neuroradiologist practicing medicine in Ypsilanti, Michigan. Dr. Kasotakis is rated as an Advanced provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Stroke, Vertigo, Headache, and CAPOS Syndrome.

Michael Sarosi is an Interventional Radiologist practicing medicine in Ypsilanti, Michigan. Dr. Sarosi is rated as an Experienced provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Lung Nodules, Congenital Arteriovenous Shunt, Pleurisy, Thrombectomy, and Liver Embolization.

Bing Xue is an Intensive Care Medicine provider practicing medicine in Ypsilanti, Michigan. Dr. Xue is rated as an Experienced provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Lung Nodules, Obstructive Sleep Apnea, Lung Metastases, Islet Cell Transplantation, and Gastrostomy.

Rajeev Swarup is an Intensive Care Medicine provider practicing medicine in Ypsilanti, Michigan. Dr. Swarup is rated as an Experienced provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Lung Metastases, Lung Nodules, Bronchiectasis, Chronic Obstructive Pulmonary Disease (COPD), and Gastrostomy.

Arwa Hosni is an Intensive Care Medicine provider practicing medicine in Ypsilanti, Michigan. Dr. Hosni is rated as an Experienced provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Obstructive Sleep Apnea, Lung Nodules, Drowsiness, Excessive Daytime Sleepiness, and Advanced Bronchoscopy.

Robert Taila is a Radiologist practicing medicine in Ypsilanti, Michigan. Dr. Taila is rated as an Experienced provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Gallbladder Disease, Angiomyoma, and Uterine Fibroids.

Owen Stark is a Radiologist practicing medicine in Ypsilanti, Michigan. Dr. Stark is rated as an Experienced provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Lung Nodules, Ascites, Diffuse Panbronchiolitis, Liver Embolization, and Gastrostomy.

Kamal Mubarak is an Intensive Care Medicine provider practicing medicine in Ypsilanti, Michigan. Dr. Mubarak is rated as an Experienced provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Lung Metastases, Bronchiectasis, Acute Interstitial Pneumonia, and Pneumonia.

Bryan J. Schneider, MD is a Professor of Internal Medicine in the Division of Hematology/ Oncology at the University of Michigan, Ann Arbor, Michigan, and is the Section Head for the medical thoracic oncology team who treats lung cancer, esophageal cancer, mesothelioma, thymoma and carcinoid tumors.Dr. Schneider earned his medical degree from Indiana University in 1998. He also completed an internship and residency in internal medicine at the Indiana University School of Medicine and served as Chief Resident in 2001. He completed a fellowship in hematology/oncology at the University of Michigan. He joined the faculty at the University of Michigan as an Assistant Professor in 2005 and was an Assistant Professor at Cornell University in New York City from 2008 to 2014. He returned to the University of Michigan in 2015.Dr. Schneider is a member of the American Society of Clinical Oncology and the International Association for the Study of Lung Cancer. He has served as a member of the Experimental Therapeutics Study Section of the National Institutes of Health and serves on numerous other scientific medical committees. These include the ASCO thoracic guideline advisory group, and the steering committee for the National Cancer Center Network (NCCN) guidelines.Dr. Schneider has published extensively in peer-reviewed journals and has written several book chapters on the subject of lung cancer. He is married with twin boys and a cat. Dr. Schneider is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Tissue Biopsy. Dr. Schneider is board certified in Medical Oncology.

Dr. James Hayman received his medical and master of business administration degrees simultaneously from the University of Chicago in 1991. Following an internship in Evanston, Ill., he began his radiation oncology residency at the Joint Center for Radiation Therapy at Harvard Medical School. He joined the University of Michigan faculty immediately following his residency in 1996 and currently serves as the director of the Clinical Division of the Department of Radiation Oncology. Dr. Hayman's clinical interests include the management of lung, esophageal, breast and central nervous system malignancies. He is also active in the area of health services research. Dr. Hayman is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Melanoma of the Eye, Merkel Cell Carcinoma, and Small Cell Lung Cancer (SCLC). Dr. Hayman is board certified in Radiation Oncology and Hospice & Palliative Med.

Shruti Jolly MD is an Associate Professor and Associate Chair of Community Practices in the Department of Radiation Oncology at the University of Michigan. She received her undergraduate and medical degrees at Wayne State University as a Presidential Scholar. In 2007, she completed her medical training at William Beaumont Hospital in Royal Oak, Michigan where she served as chief resident and received the RSNA Roentgen Resident Research Award. Dr. Jolly then joined the faculty at the University of Michigan Department of Radiation Oncology. Dr. Jolly directs the treatment of thoracic, gynecologic and endocrine malignancies. She also serves as the director of Brachytherapy, specializing in High Dose Rate (HDR) brachytherapy procedures. Additionally, she is the principal investigator of numerous clinical protocols designed to individualize the radiation therapy of lung and gynecologic cancer patients. Dr. Jolly has authored numerous publications in peer-reviewed journals. As Associate chair of Community Practices, she oversees the standardization and quality of care of patients receiving radiation therapy at the numerous UM Radiation Oncology community practices across the state of Michigan. In addition she also serves as a consultant for the Michigan Radiation Oncology Quality Consortium (MROQC) focused on quality improvement in patients undergoing radiation therapy for breast cancer, lung cancer and bone metastases. Dr. Jolly is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Adrenal Cancer, and Pleuropulmonary Blastoma. Dr. Jolly is board certified in Radiation Oncology.

Dr. Vaishampayan is the Director of the Phase I program at the Rogel Cancer Center, University of Michigan, Ann Arbor MI. Dr. Vaishampayan is a Professor of Internal Medicine and her research is primarily in translational drug development and early phase clinical trials in cancer with a focus on genitourinary malignancies. She has initiated, obtained funding for, and conducted and published many investigator initiated trials with embedded biomarkers and established multidisciplinary collaboration. She has served as site PI of the UO-1 Early Therapeutics Research Grant at Wayne State University. She was also the chair of the solid tumor division of oncology at WSU. She has completed formal leadership traning course and is Fellow of the Advisory Board (FAB). She is the appointed chair of the Advanced Renal committee of SWOG and a member of the Renal task force of the NCI. She is a board member of the Michigan Society of Hematology/Oncology (MSHO) and organizes annual board review course. Additionally, she has served as track leader for the ASCO education committee GU non prostate (Renal and bladder cancer) track. Dr. Vaishampayan attended Wayne State University for her residency and fellowship completion and attended medical school at Byramjee Jeejeebhoy in Pune, India and completed a higher secondary certificate in the field of science at Fergusson College in Pune, India.In her free time, Dr. Vaishampayan enjoys reading, dance, music and travel. Travel, reading (mysteries preferred), follows football. Dr. Vaishampayan is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). She is also highly rated in 36 other conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Urothelial Cancer, Nephrectomy, and Orchiectomy. Dr. Vaishampayan is board certified in Medical Oncology.

Dr. De Cardenas is the Director of the Interventional Pulmonology Program at the University of Michigan and a Clinical Associate Professor of Medicine and Surgery. He is part of the multidisciplinary team at the University of Michigan that treats patients with complex airway and pleural diseases. He has specific expertise in minimally invasive advanced diagnostic and therapeutic bronchoscopic and pleural procedures, critical care ultrasonography and medical education. His academic interests include endobronchial device development for treatment of early lung cancer, pleural infectious diseases, and developing novel methods to teach procedural skills.Honors and Awards:2017 Nominee Emerging Educator Award - Association of Pulmonary and Critical Care Medicine Program Directors (APCCMPD)2014 Fellow of the Year, Department of Medicine. Zucker School of Medicine at Hofstra Northwell, NY2012 Best Teaching Senior Resident, Leo M. Davidoff Society Awards, Albert Einstein College of Medicine2011 Best Teaching Junior Resident, Leo M. Davidoff Society Awards, Albert Einstein College of Medicine2010 Best Teaching Intern, Leo M. Davidoff Society Awards, Albert Einstein College of MedicineCredentials:Medical SchoolMD, Facultad de Medicina. Universidad Nacional de Trujillo, Peru 2006ResidencyAlbert Einstein College of Medicine, Jacobi Medical Center, Internal Medicine, NY 2012FellowshipsHarvard Medical School, Combined Interventional Pulmonology Fellowship. Beth Israel Deaconess Medical and Massachusetts General Hospital, Boston, MA, 2016Zucker School of Medicine. Pulmonary and Critical Care Medicine, North Shore University Hospital and Long Island Jewish Medical Center, NY 2015Board Certifications2012: Board Certification in Internal Medicine2014: Board Certification in Pulmonary Medicine2016: Board Certification in Critical Care Medicine2017: Board Certification in Interventional Pulmonology. AABIP. Dr. De Cardenas is rated as an Advanced provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Lung Nodules, ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Advanced Bronchoscopy, and Endoscopy. Dr. De Cardenas is board certified in Pulmonary Disease, Critical Care Medicine, and Interventional Pulmonology.

Dr. Hyzy is the Medical Director of the Critical Care Medicine Unit and Co-Chair of the Critical Care Committee at the University of Michigan Hospital. Dr. Hyzy is a graduate of Kenyon College and NYU School of Medicine and trained in Internal Medicine and Pulmonary and Critical Care Medicine at the University of Michigan. Dr. Hyzy’s research interest in thin the intensive care unit including patients with the Acute Respiratory Distress Syndrome, sepsis and respiratory failure. In the Pulmonary Clinic he participated as a Co-Investigator in clinical trials in patients with Idiopathic Pulmonary Fibrosis and COPD. Dr. Hyzy is an active clinician and researcher with multiple publications including serving as editor of a critical care textbook published by Springer and 14 topics to the online medical reference UpToDate. Dr. Hyzy is rated as an Advanced provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Pneumonia, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Idiopathic Pulmonary Fibrosis.